A large research and teaching hospital in Milan whose haematology units carry out blood stem cell transplants, CAR-T cell therapy and approved gene therapy for children and adults.
IRCCS Ospedale San Raffaele is a large research and teaching hospital at Via Olgettina 60 in Milan. The letters IRCCS stand for Istituto di Ricovero e Cura a Carattere Scientifico, the Italian designation for a hospital recognised by the state for scientific research alongside clinical care. It is a general hospital with many departments, not a private cell therapy clinic, and it is listed here for its established cell therapy and transplant programmes.
The hospital's haematology and bone marrow transplant unit states that it performs haematopoietic stem cell transplants — that is, transplants of the blood-forming stem cells found in bone marrow. Its page describes autologous transplants (using the patient's own cells), allogeneic transplants (using a donor's cells) and haploidentical transplants (using a half-matched family donor). The same unit states that it provides CAR-T cell therapy, in which a patient's immune cells are modified in a laboratory before being returned, and gene therapy. It gives figures of about 150 transplants and 20 CAR-T treatments each year.
A separate paediatric immunohaematology unit states that it performs haematopoietic stem cell transplants in children using matched family donors, half-matched family donors and unrelated registry donors, and that it delivers approved gene therapy for adenosine deaminase deficient severe combined immunodeficiency, a rare inherited immune disorder. Its page states that 110 children have been treated with gene therapy based on blood-forming stem cells, and that clinical trials continue in beta thalassaemia, Wiskott-Aldrich syndrome and metachromatic leukodystrophy.
This is hospital medicine delivered through specialist units and, in several of the areas above, through clinical trials. Access is by referral into the relevant unit rather than by direct booking, and the site publishes no price list. Prospective patients should note that gene therapy and CAR-T work described here applies to specific named disorders and is not offered as a general treatment.
The hospital's haematology and paediatric immunohaematology units name the following among the conditions they treat.
The hospital states that its cell therapy work is transplant and gene therapy medicine in haematology — blood-forming stem cells and laboratory-modified immune cells for named blood, immune and inherited disorders — rather than injections for general musculoskeletal or cosmetic complaints.
The hospital names the following among the clinicians leading its cell therapy and transplant units.
The hospital is a large campus at Via Olgettina 60 in the north-east of Milan, holding many clinical departments together with research institutes. The haematology unit's page places its inpatient ward in sector D on the second floor, its day hospital in sector Q1 on the second floor and its outpatient clinic in sector R on the lower ground floor, with secretariat hours of Monday to Friday, 8am to 3.30pm. The hospital carries the Italian IRCCS designation for a research hospital. The site does not state a founding year on the pages read.
The site publishes no prices for transplant, CAR-T or gene therapy. These are hospital services reached by clinical referral within the Italian health system, and the pages read give no indication of self-funded pricing.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.